Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, S A Im, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi methodP-J Cuyle, K Geboes, S Carton, et al.
Breast Cancer Research and Treatment|November 30, 2019
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancerAnouk K M Claessens, Reinier Timman, Jan J Busschbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300Y-J Bang, E Yañez Ruiz, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)R A Popescu, R Schäfer, R Califano, et al.
Human Reproduction (Oxford, England)|April 15, 2011
Reproductive status in adult male long-term survivors of childhood cancerK Tromp, J J M Claessens, S L Knijnenburg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III studyT Yoshino, D C Portnoy, R Obermannová, et al.
Medicine and Science in Sports and Exercise|September 9, 2004
Growth in peak aerobic power during adolescenceChristina A Geithner, Martine A Thomis, Bavo Vanden Eynde, et al.
Pageof 32